The SA Journal Diabetes & Vascular Disease Vol 7 No 4 (November 2010) - page 34

A leading partner
in the field of diabetic research
www.servier.com
Forfullprescribing information,refertopackage insertapprovedbythemedicalregulatoryauthority. DIAMICRON® MR30mgTablets. Gliclazide30mg.Reg.No.35/21.2/0178.EachDIAMICRONModifiedRelease30mg
tabletcontains30mgGliclazide.PHARMACOLOGICALCLASSIFICATIONA21.2OralHypoglycaemics. DIAGLUCIDE® MR30mgTablets. Gliclazide30mg.Reg.No.38/21.2/0223.EachDIAGLUCIDE® ModifiedRelease30mg
tabletcontains30mgGliclazide.Reg.No.38/21.2/0223.PHARMACOLOGICALCLASSIFICATIONA21.2OralHypoglycaemics.PRODUCTREGISTRATIONNUMBER35/21.2/0178.NAMEANDBUSINESSADDRESSOFTHEHOLDER
OFTHECERTIFICATE:ServierLaboratoriesSouthAfrica (PTY)LTD (RegNo.72/14307/07).DevconPark,7AutumnStreet,Rivonia,2128.Tel:+27(0)11233-6000.FAX:+27(0)11233-6099.NAMEANDBUSINESSADDRESSOF
THE HOLDER OF THE CERTIFICATE: Biogaran South Africa (Pty) Ltd. Reg. No. 2001/011749/07. P O Box 2962, Rivonia, 2128. Tel: (011) 233 6026. Fax (011) 233 6098. References: 1. ADVANCE N Eng J Med 2008;358;2560-72